Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David W Grainger

Showing results (11-20 of 160) with videos related to

Pageof 16
Sort By:
Journal of Proteome Research|November 4, 2006
Comparison of hydroxylated print additives on antibody microarray performancePeng Wu, David W Grainger
Advanced Drug Delivery Reviews|September 28, 2011
RNA therapeutics targeting osteoclast-mediated excessive bone resorptionYuwei Wang, David W Grainger
Biomaterials|December 13, 2005
Drug/device combinations for local drug therapies and infection prophylaxisPeng Wu, David W Grainger
Advanced Drug Delivery Reviews|March 23, 2019
Lyophilized liposome-based parenteral drug development: Reviewing complex product design strategies and current regulatory environmentsYuwei Wang, David W Grainger
Archives of Toxicology|March 14, 2019
A murine ex vivo 3D kidney proximal tubule model predicts clinical drug-induced nephrotoxicityDorina Diekjürgen, David W Grainger
Pharmaceutical Research|March 25, 2010
siRNA knock-down of RANK signaling to control osteoclast-mediated bone resorptionYuwei Wang, David W Grainger
Methods in Molecular Biology (Clifton, N.J.)|November 7, 2007
Nonfouling surfaces: a review of principles and applications for microarray capture assay designsPing Gong, David W Grainger
Biomaterials|July 4, 2017
Polysaccharide matrices used in 3D in vitro cell culture systemsDorina Diekjürgen, David W Grainger
Pflugers Archiv : European Journal of Physiology|May 11, 2018
Drug transporter expression profiling in a three-dimensional kidney proximal tubule in vitro nephrotoxicity modelDorina Diekjürgen, David W Grainger
Therapeutic Delivery|October 15, 2013
Developing siRNA therapies to address osteoporosisYuwei Wang, David W Grainger
Pageof 16

Showing results (11-20 of 160) with videos related to

Sort By:
Pageof 16
Journal of Proteome Research|November 4, 2006
Comparison of hydroxylated print additives on antibody microarray performancePeng Wu, David W Grainger
Advanced Drug Delivery Reviews|September 28, 2011
RNA therapeutics targeting osteoclast-mediated excessive bone resorptionYuwei Wang, David W Grainger
Biomaterials|December 13, 2005
Drug/device combinations for local drug therapies and infection prophylaxisPeng Wu, David W Grainger
Advanced Drug Delivery Reviews|March 23, 2019
Lyophilized liposome-based parenteral drug development: Reviewing complex product design strategies and current regulatory environmentsYuwei Wang, David W Grainger
Archives of Toxicology|March 14, 2019
A murine ex vivo 3D kidney proximal tubule model predicts clinical drug-induced nephrotoxicityDorina Diekjürgen, David W Grainger
Pharmaceutical Research|March 25, 2010
siRNA knock-down of RANK signaling to control osteoclast-mediated bone resorptionYuwei Wang, David W Grainger
Methods in Molecular Biology (Clifton, N.J.)|November 7, 2007
Nonfouling surfaces: a review of principles and applications for microarray capture assay designsPing Gong, David W Grainger
Biomaterials|July 4, 2017
Polysaccharide matrices used in 3D in vitro cell culture systemsDorina Diekjürgen, David W Grainger
Pflugers Archiv : European Journal of Physiology|May 11, 2018
Drug transporter expression profiling in a three-dimensional kidney proximal tubule in vitro nephrotoxicity modelDorina Diekjürgen, David W Grainger
Therapeutic Delivery|October 15, 2013
Developing siRNA therapies to address osteoporosisYuwei Wang, David W Grainger
Pageof 16